ArticleJournal of enzyme inhibition and medicinal chemistry2023

Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug.

BoRa Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.